Two-Drug Combo Shows Dramatic Results for COVID-19 Patients, UF Health Researchers Find
Combining an anti-inflammatory drug with an antiviral drug reduces recovery time and accelerates improvement for COVID-19 patients, a national study co-authored by UF Health researchers has found.
Florida Doctors Push To Make COVID-19 Vaccine Education Accessible in Minority Communities
Data shows that racial and ethnic minorities are more at risk of getting COVID-19, being hospitalized and dying from the virus. There are so many reasons for this disparity: socioeconomic status increased exposure to the virus because of occupation, access to healthcare and education.
Can Scientists Speed up Growth of Citrus Trees?
The ability to kick-start the growing process of plants is a superpower that has a universal appeal for producers of all crops. A new University of Florida research project aims to improve citrus plant performance and productivity by providing breeders with traits to enhance the photosynthesis of cultivated crops.
UF Offers Powerful New NVIDIA Supercomputer to Students, Researchers Across Florida
University of Florida’s new supercomputer — the fastest artificial intelligence supercomputer in higher education — will soon be available for students and faculty across the State University System, UF Provost Joe Glover announced.
Purina Announces 2021 Pet Care Innovation Prize Winners
UF startup Structured Monitoring Products' VetGuardian was among the five winners. VetGuardian is a zero-touch remote telemonitor for veterinarians that continuously gathers a patient's vital signs without wires or physical contact.
Odyssey Group International’s Planned Acquisition of Concussion Drug from Prevacus, Inc. Enhances Delivery Capabilities with Nasal Therapeutic
Odyssey Group International is circulating a video to better define its drug candidate PRV-002, a therapeutic compound drug to treat concussion (mild traumatic brain injury (mTBI), from UF Innovate | Sid Martin Biotech alum Prevacus Inc. Odyssey is expected to acquire PRV-002 by the end of February.
Research Provides Insights Into Citrus Greening Disease
Researchers used molecular plant pathology approaches to dissect the mechanisms of the ongoing tug-of-war between the citrus host and the bacterial pathogen that causes citrus greening disease.
Two-Drug Combo Shows Dramatic Results for COVID-19 Patients, UF Health Researchers Find
Combining an anti-inflammatory drug with an antiviral drug reduces recovery time and accelerates improvement for COVID-19 patients, a national study co-authored by UF Health researchers has found.
Skin Cancer Vaccine Developed by Tampa Company Enters Phase 1 of Clinical Trial
UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc. completed its first-in-human phase one trial in cutaneous melanoma at Moffitt Cancer Center within the past year and has now moved into studying patients in earlier stages of skin cancers.
UF Health Researcher Answers Top Questions About the New COVID-19 Vaccines
The leading COVID-19 vaccines aren’t anything like the polio vaccination your grandparents received — or even the flu shot you got this fall. A look under the hood unveils a remarkable advancement in medicine.
